Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA000452 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA000452, RRID:AB_1079177
- Product name
- Anti-KRT17
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human KRT17, Gene description: keratin 17, type I, Alternative Gene Names: PCHC1, Validated applications: ICC, IHC, WB, Uniprot ID: Q04695, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis
Cytoskeletal protein flightless I inhibits apoptosis, enhances tumor cell invasion and promotes cutaneous squamous cell carcinoma progression
Scalable In Situ Hybridization on Tissue Arrays for Validation of Novel Cancer and Tissue-Specific Biomarkers
Strunz M, Simon L, Ansari M, Kathiriya J, Angelidis I, Mayr C, Tsidiridis G, Lange M, Mattner L, Yee M, Ogar P, Sengupta A, Kukhtevich I, Schneider R, Zhao Z, Voss C, Stoeger T, Neumann J, Hilgendorff A, Behr J, O’Reilly M, Lehmann M, Burgstaller G, Königshoff M, Chapman H, Theis F, Schiller H
Nature Communications 2020;11(1)
Nature Communications 2020;11(1)
Cytoskeletal protein flightless I inhibits apoptosis, enhances tumor cell invasion and promotes cutaneous squamous cell carcinoma progression
Kopecki Z, Yang G, Jackson J, Melville E, Caley M, Murrell D, Darby I, O’Toole E, Samuel M, Cowin A
Oncotarget 2015;6(34):36426-36440
Oncotarget 2015;6(34):36426-36440
Scalable In Situ Hybridization on Tissue Arrays for Validation of Novel Cancer and Tissue-Specific Biomarkers
Srivastava R, Kiflemariam S, Andersson S, Asplund A, Pontén F, Sjöblom T
PLoS ONE 2012;7(3):e32927
PLoS ONE 2012;7(3):e32927
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human urinary bladder and lymph node tissues using HPA000452 antibody. Corresponding KRT17 RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol